Beginning this month, a new Medicare local coverage determination reduces the number of conditions under which anesthesia services can be reimbursed for interlaminar and transforaminal epidural steroid injections. The determination addresses payment limitations, and, according to Mr. Mira, “the overall takeaway is that these services will rarely be reimbursed to anesthesiologists and anesthetists.”
Mr. Mira recommends that service providers document any patient conditions that might help to establish the medical necessity of the service and have the patient complete and sign an advance beneficiary notice form.
Read more about the new policy here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
